The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
about
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.The genetics and neuropathology of Parkinson's diseaseGlucocerebrosidase and Parkinson disease: Recent advancesThe relationship between glucocerebrosidase mutations and Parkinson diseaseParkinson disease in Gaucher disease.Adult Gaucher disease in southern Tunisia: report of three casesRevised recommendations for the management of Gaucher disease in children.Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher diseaseComparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.Multi-system disorders of glycosphingolipid and ganglioside metabolismThe risk of Parkinson's disease in type 1 Gaucher disease.Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.Gaucher disease: insights from a rare Mendelian disorder.The link between the GBA gene and parkinsonismThe diagnosis of young-onset dementia.Hyposmia and cognitive impairment in Gaucher disease patients and carriersGaucher disease and its treatment options.A reappraisal of Gaucher disease-diagnosis and disease management algorithms.Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.Parkinsonism associated with glucocerebrosidase mutation.Olfactory dysfunction in LRRK2 G2019S mutation carriersCNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathySynthesis and Evaluation of Hybrid Structures Composed of Two Glucosylceramide Synthase Inhibitors.Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.Glucocerebrosidase activity in Parkinson's disease with and without GBA mutationsProgression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease.The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flowOlfaction in Parkinson's disease and related disorders.GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease.Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher diseasePremotor biomarkers for Parkinson's disease - a promising direction of research.Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counselingThe role of glucocerebrosidase mutations in Parkinson disease and Lewy body disordersClinical course and prognosis in patients with Gaucher disease and parkinsonismA New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonismGlucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent.Glycosphingolipids--nature, function, and pharmacological modulation.Laboratory and genetic evaluation of Gaucher disease.
P2860
Q24634577-C804E49D-9A9F-4345-95A4-9BA2338DE94EQ26859945-D1CB81DB-3320-4B74-B51C-D70657E30013Q27005669-00CDC8C8-5343-4FCC-8CB7-C2E9EEB2F46CQ28077257-D527B1D0-40A1-4B6D-923F-F1C3F1AFBC71Q30852543-25D2D5CF-9129-483E-B34C-FF8FB87A0234Q33399105-59398E45-EA5F-484B-BE74-63D83BB71894Q33402191-FA3D8A62-6C2C-4832-8062-B6B6E511985FQ33478327-7598DCDA-44C7-48F6-8536-9DC70D0C1881Q33849233-E36DD42F-2DC4-453A-9892-2B3DB8A173FBQ33902037-52D6605A-7968-4CFC-A268-7883A14702B1Q33919614-028F7715-99F6-4F55-8CB4-3BFF1FECBE32Q34037141-6C18B3EB-E230-47F7-B9A1-AD7DF56F2FD5Q34077331-BDED7F91-4DB3-4D70-8EE0-A541994DEC27Q34077492-C3D57A4C-9CB7-4FB5-A608-5AE2F6EBC223Q34165340-91876834-DCE0-4782-B2C7-7278B07CF234Q34300690-1BF94618-4D81-479D-AD50-2446F44B3475Q34386658-24DB15B2-9BD3-48CB-9340-F390D9ED0CA4Q34683786-6EF6829F-87DE-445F-B3B2-10E46BADB187Q35028532-7A7E1EAF-5066-4051-8881-881E5DE7BC28Q35091693-CD21B70B-FCF3-4751-8ECA-CC44F8B622A1Q35119617-F23F7A9B-C60C-4D76-B8F2-B4192676B722Q35122963-0ED58954-3BDB-4078-8147-14E9CA8759FBQ35817623-7AC6EAF6-BDFD-4CFC-BC3C-705A2F5BB8CAQ35960413-03A32319-615E-419B-A32D-876DEAC1F40CQ36041420-4F57F432-9257-476F-8D29-D4208541F5A3Q36123828-29C4ADF7-6857-4A13-8C73-8FF8BA676F1CQ36124421-FE1AE7CD-BC84-437D-8F27-A606D099A9D3Q36193915-3F988979-C91D-44FD-9A1B-BCF6FFBA49D6Q36234536-9C65CED9-453B-48FE-9F85-379511038994Q36389683-10F585F8-5730-4F59-A23F-F14179E311FBQ36398099-68628314-FAC8-43A2-B5A1-F3D89033C2A1Q36444517-8B8FC45C-BDE8-44B7-984C-D41B6DEC94AAQ36460324-8E25B772-077F-48F0-838B-40A47ED86E83Q36486264-F20CF046-247A-4B5D-AB8A-09D326383299Q36794066-B8C5B8FE-199D-46DA-BA9C-2CB3E5446DE2Q37096051-FA8B4570-42D7-48A9-AC34-22AEA3AF446CQ37329304-E84630CA-1013-4BDF-9DCA-997A0558036DQ37520646-7C6A9618-3397-4D6D-928C-BD3555736B6FQ37622816-6003F498-1426-431A-864F-6F5863F6FC7CQ37780488-640A0C3F-E0B4-41F2-8976-C949160D44A9
P2860
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
@en
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
@nl
type
label
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
@en
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
@nl
prefLabel
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
@en
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
@nl
P2093
P2860
P1433
P1476
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
@en
P2093
Ellen Sidransky
Grisel Lopez
Joie Davis
Joseph Vithayathil
Ozlem Goker-Alpan
P2860
P304
P356
10.1001/ARCHNEUR.65.10.1353
P50
P577
2008-10-01T00:00:00Z